Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Cytokinetics Inc (CYTK)

  • Event
  • Oct. 10, 2022, 04:31 UTC
  • 116
  • 0 comments

Cytokinetics Announces Continuation of COURAGE-ALS Following First Interim Analysis

Comment Full text

Axsome Therapeutics Inc (AXSM)

  • Event
  • Oct. 10, 2022, 04:03 UTC
  • 111
  • 0 comments

Axsome Therapeutics Voices its Commitment to Mental Health on World Mental Health Day 2022

Comment Full text

Passage Bio Inc (PASG)

  • Event
  • Oct. 10, 2022, 04:02 UTC
  • 116
  • 0 comments

Passage Bio, Inc. - Corporate Presentation - October 2022

Comment Full text

Compugen Ltd (CGEN)

  • Event
  • Oct. 07, 2022, 09:20 UTC
  • 113
  • 0 comments

Compugen - Video Recording of Immuno UK Presentation Available

Comment Full text

Allogene Therapeutics Inc (ALLO)

  • Event
  • Oct. 06, 2022, 20:20 UTC
  • 33
  • 1 comments

(10% Negative) Allogene Therapeutics, Inc. (ALLO) Announces Clinical Trial Timeline Adjustment

Comment Full text

Mirum Pharmaceuticals Inc (MIRM)

  • Event
  • Oct. 06, 2022, 10:41 UTC
  • 117
  • 0 comments

Mirum Pharma - Corporate Presentation – October 2022

Comment Full text

Seagen Inc (SGEN)

  • Event
  • Oct. 06, 2022, 05:03 UTC
  • 111
  • 0 comments

Seagen - Third Quarter 2022 Financial Results

Comment Full text

Taysha Gene Therapies (TSHA)

  • Event
  • Oct. 06, 2022, 04:03 UTC
  • 117
  • 0 comments

Taysha Gene Therapies Announces Presentationsat the Upcoming 29th Annual Meeting ofthe European Society of Gene & CellTherapy (ESGCT)

Comment Full text

Compugen Ltd (CGEN)

  • Event
  • Oct. 06, 2022, 04:02 UTC
  • 116
  • 0 comments

Compugen - Compugen to Present New Clinical and Research Data in Two Oral Presentations at SITC 2022

Comment Full text

Cellectis (CLLS)

  • Event
  • Oct. 05, 2022, 20:30 UTC
  • 20
  • 1 comments

(99% Neutral) Cellectis (CLLS) Files Form 6-K

Comment Full text
  • Previous
  • 108
  • 109
  • 110
  • 111
  • 112
  • Next

Search

News categories

  • Technical Exchange News(10868)
  • Event(2240)
  • SEC News(188975)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124485)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin